GEN Exclusives

More »

The Lists

More »
Aug 19, 2013

The Top 50 NIH-Funded Universities

Which schools earned the most funding this year?

The Top 50 NIH-Funded Universities

Last year’s edition of the NIH list only ranked the top 25 institutions. This year, we’re going up to 50. [© Sergey Nivens - Fotolia.com]

  • Below is a list of 50 universities, including medical schools, ranked by how much in NIH funding they have received during the current 2013 federal fiscal year through August 5 (FY 2012 ends on September 30) and the number of grant awards funded.

    This year’s list has been expanded from last year’s edition of the NIH list, which ranked the top 25 institutions. The expanded list makes evident several observations. One is the dominance of California institutions, driven by the success in winning NIH grants enjoyed by some of the largest schools in the University of California system. In all, six UC schools appear on this year’s list—UC San Francisco, UC San Diego, and UCLA, which all made the top 10; followed further down by UC Davis, UC Irvine, and UC Berkeley. Among the Golden State’s private institutions, Stanford University and University of Southern California (USC) placed in the list’s top half. Second-best state for winning NIH funds is Massachusetts.

    The list does not include research institutes or institutions primarily known for being teaching/research hospitals or clinical care centers that are not denoted by name as being part of university systems. As a result, the next largest concentration of ranked institutions on this list—NIH top-funded universities and medical schools—can be found in New York (5), followed by Massachusetts (4). Illinois and Texas each have three universities or med schools on the list.

    Research institutes, while receiving millions from NIH, aren’t on top of this list, most likely because they have less need for government funds since they can draw on other resources, whether it be gifts from the foundations that established them, or their own fundraising.

  • #34. University of Iowa

    FY 2013: $107,469,884 toward 288 awards

  • #33. University of Texas (UT) Southwestern Medical Center

    FY 2013: $108,713,006 toward 311 awards

  • #32. University of Maryland Baltimore

    FY 2013: $109,440,859 toward 266 awards

  • #31. New York University School of Medicine

    FY 2013: $113,956,870 toward 282 awards

  • #30. University of Rochester

    FY 2013: $119,478,341 toward 297 awards

  • #29. Case Western Reserve University

    FY 2013: $121,040,324 toward 284 awards

  • #28. University of Chicago

    FY 2013: $122,918,492 toward 297 awards

  • #27. Albert Einstein College of Medicine

    FY 2013: $127,180,651 toward 269 awards

  • #26. Northwestern University at Chicago

    FY 2013: $127,904,528 toward 336 awards

  • #25. University of Alabama at Birmingham

    FY 2013: $128,032,911 toward 325 awards

  • #24. University of Colorado Denver

    FY 2013: $129,408,296 toward 358 awards

  • #23. Harvard University (Medical School)

    FY 2013: $131,067,454 toward 292 awards

  • #22. University of Southern California

    FY 2013: $131,772,721 toward 272 awards

  • #21. University of California, Davis

    FY 2013: $134,072,241 toward 336 awards

  • #20. Baylor College of Medicine

    FY 2013: $143,535,778 toward 321 awards

  • #19. Oregon Health and Science University

    FY 2013: $157,193,264 toward 350 awards

  • #18. University of Wisconsin-Madison

    FY 2013: $192,748,376 toward 488 awards


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?